Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder

2013 ◽  
Vol 151 (3) ◽  
pp. 967-972 ◽  
Author(s):  
Yun-Hsuan Chang ◽  
Sheng-Yu Lee ◽  
Shiou-Lan Chen ◽  
Nian-Sheng Tzeng ◽  
Tzu-Yun Wang ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Anxiety Disorder ◽  
Genetic Variants

Reversal learning in youth with generalized anxiety disorder and bipolar disorder

2014 ◽  
Author(s):  
Grace K. Cushman ◽  
Megan E. Puzia ◽  
Alexandra B. Weissman ◽  
Ezra Wegbreit ◽  
Kerri L. Kim ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Reversal Learning ◽  
Generalized Anxiety

The Prevalence of Comorbid Anxiety in Schizophrenia, Schizoaffective Disorder and Bipolar Disorder

1998 ◽  
Vol 32 (1) ◽  
pp. 67-72 ◽  
Author(s):  
Susan J. Cosoff ◽  
R. Julian Hafner
Keyword(s):  
Bipolar Disorder ◽  
Anxiety Disorder ◽  
Anxiety Disorders ◽  
Schizoaffective Disorder ◽  
Psychiatric Symptoms ◽  
Psychotic Episode ◽  
Obsessive Compulsive ◽  
General Anxiety ◽  
Admission Rates ◽  
Clinical Benefits

Objective: The aim of this study to determine the prevalence of anxiety disorders in publically treated psychiatric inpatients with a DSM-IV diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder. Method: Using the Structured Clinical Interview for DSM-III-R (SCID), 100 consecutive inpatients with a psychotic disorder were examined for the presence or absence of an anxiety disorder. Questionnaire measures of phobias, obsessive-compulsive and general anxiety symptoms were also applied. Results: The prevalences of social phobia (17%), obsessiv-ompulsive disorder (13%) and generalised anxiety disorder in schizophrenia were relatively high, as were prevalences of obsessive-compulsive (30%) and panic disorder (15%) in bipolar disorder. The proportion of subjects with an anxiety disorder (4345%) was almost identical across the three psychoses, with some evidence of gender differences. Although self-ratings of overall psychiatric symptoms were significantly elevated in those with anxiety disorders, hospital admission rates were not. Conclusions: Almost none of those with anxíeGty disorders were being treated for them, primarily because the severity of the acute psychotic illness required full diagnostic and therapeutic attention. Patients were generally discharged as soon as their psychotic episode was resolved, with little recognition of the presence of an anxiety disorder. Given that anxiety disorders are relatively responsive to treatment, greater awareness of their comorbidity with psychosis should yield worthwhile clinical benefits.

scholarly journals Comparative efficacy and safety of different drugs for bipolar disorder complicated with anxiety disorder

Medicine ◽  
2020 ◽  
Vol 99 (38) ◽  
pp. e22280
Author(s):  
Li Yang ◽  
Meili Yan ◽  
Li Du ◽  
Shasha Hu ◽  
Zhigang Zhang
Keyword(s):  
Bipolar Disorder ◽  
Anxiety Disorder ◽  
Efficacy And Safety ◽  
Comparative Efficacy

Quetiapine. A collection of useful information for the clinician

2021 ◽  
Vol 14 (2) ◽  
pp. 182-185
Author(s):  
Marcin Siwek
Keyword(s):  
Bipolar Disorder ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Antipsychotic Drug ◽  
Medical Practice ◽  
Anxiety Symptoms ◽  
Use Cases ◽  
Generalized Anxiety ◽  
Recurrent Depression ◽  
Proven Efficacy

Quetiapine is an antipsychotic drug with proven efficacy in the treatment of schizophrenia and bipolar disorder as well as recurrent depression and generalized anxiety disorder. There is also evidence of the efficacy of quetiapine in other disorders dominated by affective and/or anxiety symptoms, for which treatment is not registered in Poland. The paper presents information useful in medical practice and presents descriptions of use cases.

The Unified Protocol for Bipolar and Comorbid Disorders

2017 ◽  
pp. 86-110
Author(s):  
Kristen K. Ellard ◽  
Emily E. Bernstein ◽  
Andrew A. Nierenberg ◽  
Thilo Deckersbach
Keyword(s):  
Bipolar Disorder ◽  
Anxiety Disorder ◽  
Emotional Disorders ◽  
Emotion Dysregulation ◽  
Transdiagnostic Treatment ◽  
Comorbid Anxiety ◽  
Unified Protocol ◽  
Target Emotion ◽  
Bipolar Patients ◽  
Affective Lability

Bipolar disorder is a chronic and severe mental disorder characterized by affective lability and emotion dysregulation. In addition, it is associated with high rates of comorbidity, particularly with anxiety disorders. Approximately 90% of bipolar patients have been diagnosed with at least one comorbid anxiety disorder across the lifespan, with as many as two-thirds of patients meeting criteria for comorbid anxiety disorder at any given time. As such, transdiagnostic treatments that directly target emotion dysregulation in bipolar disorder are needed. In this chapter, we discuss evidence supporting an emotion dysregulation model of bipolar disorder and its roots in neuroticism. We then present a recent case of a patient with bipolar disorder with comorbid anxiety who received 18 sessions of treatment with the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP).

P.2.e.032 Anxiety disorder comorbidity in patients with bipolar disorder

2011 ◽  
Vol 21 ◽  
pp. S436-S437
Author(s):  
E. Toprak ◽  
O. Karamustafalioglu ◽  
B. Goksan Yavuz ◽  
B. Bakim ◽  
O. Ozer
Keyword(s):  
Bipolar Disorder ◽  
Anxiety Disorder

Can Comorbid Bipolar Disorder Be Associated with Atypical Depression in Patients with Social Anxiety Disorder ?

2019 ◽  
pp. 1
Author(s):  
Ava Tav ◽  
Tonguç Berkol ◽  
Yusuf Yıldırım ◽  
Hanife Yılmaz ◽  
Zengibar Özarslan ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Atypical Depression
Sign in / Sign up

Export Citation Format

Share Document